Search

everythinglearnresearchcommunity

for

Search:↓

Hirsutism in teens is often due to polycystic ovarian syndrome and needs careful assessment and support.

Follicular targeting could improve hirsutism treatment by focusing directly on hair follicles.

The article concludes that better diagnosis and management of Polycystic Ovarian Syndrome are needed to improve women's health and prevent related diseases.

The PCOS questionnaire is valid for Indian women, but metformin doesn't significantly improve symptoms beyond oral contraceptives.

Girls with PCOS and menstrual disorders have notably higher androgen hormone levels.

The guideline offers recommendations for diagnosing and managing PCOS and its complications.

The document concludes that treatments for female hair loss and excess body hair are available, but managing expectations is important.

Hormonal treatments can help with hair loss, acne, and excess hair growth, but it takes 3-6 months to see results and patients should know the possible side effects.

Thyroid disease can cause hair loss and treating thyroid problems might help with hair disorders.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

Alopecia areata causes hair loss, has no cure, and various treatments exist.

TRP channels in the skin are important for sensation and health, and targeting them could help treat skin disorders.

C60 fullerenes can alter protein function and may help develop new disease inhibitors.

Activating TRPV3 stops human hair growth.

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

Alopecia Areata is an autoimmune condition often starting before age 20, with varied treatment success and a need for personalized treatment plans.

The document concludes that minoxidil and finasteride are proven for hair growth, herbal remedies show promise, but more research is needed to confirm their effectiveness.

Topical drugs and near-infrared light therapy show potential for treating alopecia.

Advanced nanocarrier and microneedle drug delivery methods are more effective, safer, and less invasive for treating skin diseases.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

Despite progress in treatment, the exact cause of Alopecia areata is still unknown.

Jojoba oil is highly valued for its diverse medicinal and industrial uses.

People with atopic dermatitis are more likely to develop other skin conditions due to shared genetics and immune pathways.

Microneedle arrays with nanotechnology show promise for painless drug delivery through the skin but need more research on safety and effectiveness.

The document suggests using standardized methods to track and measure hair loss in alopecia areata, including patient self-assessment and a 50% improvement in specific scores as a treatment goal.

Patient had scalp allergy from minoxidil; test helped identify cause and suggest alternative treatments.

The document concludes that there are various treatments for different types of alopecia, but more research is needed for evidence-based treatments.

Hair loss in teenagers is hard to treat and lacks a cure, with some treatments available depending on the type of hair loss.

Alopecia areata, a type of hair loss, is likely an autoimmune disease with a genetic link, but its exact cause is still unknown.

Active transdermal technologies in cosmetics help deliver skin treatments effectively, but their safety and effectiveness depend on skin type and treatment choice.